Is CBD Oil for Pets Legal in the European Union? Full Legal Guide
Full Legal Guide and Candropharm’s legal alternative
Is CBD oil for pets legal in the European Union? Well, it’s not a straight yes or no. CBD’s legality for pets in the EU really comes down to how the product is classified—by its use, how you give it, and what’s claimed on the label. The same CBD ingredient can end up under totally different legal umbrellas, just depending on whether it’s a topical cream or an oral supplement, or if it makes any health claims at all.
What really matters is how authorities classify the product. The rules shift based on whether you’re using it topically or orally, what you’re saying it does (cosmetic care vs. health/therapeutic), and how it’s marketed—think labeling, ads, testimonials, or phrases like “for pain/anxiety.” And there’s always the looming risk: if there’s any suggestion of therapeutic intent, regulators might treat it as a veterinary medicinal product.
Regulatory uncertainty is definitely holding back the CBD pet product market across Europe, and the rules can vary wildly from country to country. If you’re a pet owner, you need to understand these categories and compliance hoops to use CBD products safely and legally. Here’s how Candropharm navigates all this complexity to bring legal CBD options for pets throughout the EU.
Key Takeaways
- CBD legality for pets in the EU depends on classification, how it’s given, and what you claim, not just the ingredient
- Most topical CBD products are treated as consumer goods—unless they make medical or biocidal claims, which triggers stricter rules
- Cross-border and national rules make for a tricky landscape—so you’ve got to pay close attention to EU safety standards
In the EU, the key legal difference is product classification. The same CBD ingredient can fall under different legal regimes depending mainly on:
Route of administration (topical vs oral)
Intended purpose / claims (cosmetic-care style vs health/therapeutic)
Presentation (labeling, advertising, testimonials, “for pain/anxiety,” etc.)
A third category is always a risk in the background: veterinary medicinal product, if therapeutic intent/claims are present.
A) CBD sold as an animal care product for external use (topical)
Typical legal “home” at EU level
If the product is marketed as a topical animal care product (e.g., balm, shampoo, spray) without medical or biocidal claims, it will often be treated as a general consumer product and must meet EU general product safety obligations. The baseline EU framework for consumer product safety is Regulation (EU) 2023/988 (General Product Safety Regulation).
When it stops being “just a care product”
Topical positioning does not automatically keep you out of stricter regimes. Two major “trigger points”:
Veterinary medicinal product (VMP) trigger
A product becomes a VMP if it is presented as treating/preventing disease in animals and/or if it is intended to modify physiological functions via a pharmacological, immunological, or metabolic action, etc. This is anchored in the definition in Regulation (EU) 2019/6 (see the “presentation criterion” in Article 4(1)(a)).Biocidal product trigger
If the product is presented as intended to kill/repel/control harmful organisms (e.g., “repels ticks/fleas,” “kills mites”), it can fall under the EU Biocidal Products Regulation (EU) 528/2012, which is a different (and potentially authorisation-driven) regime.
Practical effect:
For topical CBD products, the big compliance risk is often not the ingredient itself, but the claims and marketing presentation that can push the product into VMP or biocide territory.
B) CBD sold as an oral “feed supplement” for animals
“Feed supplement” is usually just “feed” in EU law
In EU legal terms, “supplement” is not a standalone category: an oral product for animals is typically placed on the market as feed (often “complementary feed”), and then EU feed law applies.
Core EU feed frameworks that apply
When you market an oral CBD product as feed, the main EU legal pillars are:
Regulation (EC) 767/2009: placing on the market and use of feed (labelling, presentation, claims, responsibilities).
Regulation (EC) 178/2002: general principles of food/feed law (including general safety concepts and traceability principles).
Regulation (EC) 183/2005: feed hygiene requirements for feed business operators.
Regulation (EC) 1831/2003: feed additives authorisation framework (only authorised additives may be placed/used as such).
Claims: a hard red line in feed marketing
EU feed law restricts “medical-style” claims for feed. In particular, Regulation (EC) 767/2009 states that feed labelling/presentation must not claim that the feed will prevent, treat or cure a disease (with limited exceptions such as certain authorised coccidiostats/histomonostats).
So even if a product is “only” a supplement, claims like “anti-inflammatory,” “pain relief,” “treats anxiety,” “prevents seizures,” etc. can make the product non-compliant as feed marketing and may also invite reclassification as a veterinary medicinal product depending on the overall presentation.
CBD-specific issue for the “feed supplement” route in the EU: authorisation status
A crucial extra hurdle for oral CBD products is whether CBD is regarded as a feed additive and whether it is authorised under the EU feed additives system (Reg. 1831/2003). Under that system, authorisation is a central concept (feed additives are subject to an EU authorisation framework).
Evidence from EU RASFF (Rapid Alert System for Food and Feed)
An EU RASFF notification (Reference 2024.9404, notified 19 Dec 2024; last update 28 May 2025) explicitly states that because cannabidiol (CBD) is currently not authorised as a feed additive under Regulation (EC) No 1831/2003, placing feed containing CBD on the market is not permitted.
Because authorisations can change over time, the most “future‑proof” compliance step is to verify the current situation in the EU Register of Feed Additives, which the European Commission maintains and updates.
Interaction with “medicated feed” (separate, stricter track)
If an oral product is (or contains) a veterinary medicinal product and is incorporated into feed, it can fall under the EU framework for medicated feed (Regulation (EU) 2019/4).
This is materially different from “complementary feed/supplement.”
Side-by-side comparison
| Topic | Topical animal care product (external use) | Oral “feed supplement” (usually complementary feed) |
|---|---|---|
| Primary EU framework (typical) | General consumer product safety (if sold to consumers) | Feed marketing + hygiene + general feed law |
| Biggest classification risk | VMP classification if presented as treating/preventing disease | Feed claim restrictions + possible VMP classification depending on presentation |
| “Kills/repels parasites” claims | Can trigger biocidal products regime | Still problematic; plus feed claim rules apply |
| CBD-specific hurdle | Mainly claims/presentation driven | CBD authorisation status is a major issue (RASFF states “not authorised as feed additive” → feed containing CBD not permitted, as of that notification) |
Quick screening questions (EU-focused)
Is it administered orally? → you are in feed territory and must comply with feed marketing/hygiene/additives rules.
Do you claim it treats/prevents disease, pain, anxiety, inflammation, seizures, etc.? → strong risk of veterinary medicinal product classification.
Do you claim it repels/kills ticks, fleas, mites? → possible biocidal product positioning.
If feed: have you checked whether CBD appears as authorised in the EU Register of Feed Additives?
Candropharm’s Solution for Legal and Safe Pet CBD
Candropharm tackles the complex EU regulatory maze by offering THC-free CBD products that focus on purity and compliance. We prioritise top manufacturing standards and transparent positioning, helping pet owners feel more confident about navigating the legal landscape.
Compliance and Quality Assurance
We make our CBD according to ISO 9001:2016 and HACCP guidelines, running each product through five cleaning steps during production. This careful process helps our CBD oils reach the highest purity worldwide and stay totally free from THC.
You won’t find preservatives, flavours, or additives in our products. By keeping things this simple, we avoid triggers that could classify a product as a veterinary medicinal product under Regulation (EU) 2019/6. We pay close attention to how we present and label our products to stay compliant with EU general product safety obligations.
By keeping THC at 0%, we remove worries about psychoactive effects while making sure you still get the benefits of cannabidiol.
Product Offering Highlights
Our Candrofera CBD-rich hemp oil gives pet owners a fully organic solution and legal CBD options. The oil’s mild nutty flavor usually appeals to pets, so giving it isn’t a battle.
Every batch goes through strict safety checks with our own extraction process, which keeps the cannabidiol molecule intact. We focus on quality, not bold therapeutic claims, so pet owners can use our CBD oils as animal care products without any regulatory headaches.
Our European CBD distribution keeps products available across EU member states. Still, it’s smart for pet owners to talk to their vet before starting any new supplement, especially if their animal already takes prescription meds.
Frequently Asked Questions
EU law treats CBD products for pets differently depending on how you use them and what you say about them. The classification shapes which rules apply and what paperwork you’ll need.
Candropharm can help you out to offer a legal alternative
We get that EU regulations for CBD pet products are complicated. Our team develops compliant formulas that fit EU requirements, steering clear of anything that would force veterinary medicinal product authorisation.
We help businesses position CBD products the right way under EU law. That means shaping products and claims to stay within allowed categories, all while keeping quality and effectiveness in mind.
What distinguishes a topical CBD animal care product from a veterinary medicinal product under EU regulation?
It really comes down to how you present the product and what it’s for, according to Regulation (EU) 2019/6. A topical animal care product turns into a veterinary medicinal product if you claim it treats or prevents animal disease.
If you say your product changes physiological functions through pharmacological, immunological, or metabolic action, that’s another fast track to VMP classification—even for balms or sprays.
Article 4(1)(a)’s presentation criterion looks at your marketing. Words like “healing,” “treating anxiety,” or “reducing inflammation” push a topical care product into VMP territory.
Under EU law, what triggers a product to be classified as a biocidal product, and how does this apply to CBD oil for pets?
If you claim a product kills, repels, or controls pests, it falls under the EU Biocidal Products Regulation (EU) 528/2012. For CBD pet products, saying it repels ticks, fleas, or kills mites triggers biocidal classification.
This means you’ll need different authorisation than for regular consumer products. Even topical CBDs marketed as pest deterrents have to meet biocide requirements.
We always suggest avoiding pest-control claims for topical CBD products unless you’ve secured biocidal authorisation. It’s not the ingredient itself—it’s all about how you market it.
What are the essential EU regulations that govern the marketing of oral CBD products as animal feed?
Regulation (EU) 2023/988 covers general product safety for consumer products in the EU. For oral CBD, the main framework treats these as animal feed, not as a separate supplement category.
Animal feed laws require both safety and proper labelling. The Novel Foods classification matters here, since CBD wasn’t widely consumed in the EU before 15 May 1997.
Feed business operators have to follow feed hygiene rules. That means making sure CBD products don’t have unauthorised substances or THC above allowed limits.
How do EU regulations restrict the marketing of animal feed supplements with regard to medical claims?
EU law bans animal feed from making medicinal claims. If you suggest a product treats, prevents, or cures disease, it’s immediately reclassified as a veterinary medicinal product.
Claims like “supports joint health,” “reduces anxiety,” or “treats pain” cross the line into medicinal territory. These phrases trigger VMP classification, no matter if the label says “feed” or “supplement.”
We have to describe oral CBD products with care-related language, not medical claims. Stick to general wellbeing and avoid implying medical effects.
Why is CBD authorisation status a crucial factor for oral CBD products marketed as animal feed in the EU?
CBD needs European Commission authorisation as a Novel Food after a safety assessment by the European Food Safety Authority. Without this, you can’t legally sell CBD as animal feed in the EU.
EFSA has pointed out some data gaps about CBD’s safety, especially regarding the liver, digestive system, and nervous system. Because of these uncertainties, authorisations for CBD products have been slow.
If a product contains unauthorised novel food ingredients, you simply can’t legally market it as feed. So, authorisation status is the bottom line for compliance with oral CBD pet products in the EU.
When does an oral CBD product for animals risk being classified as a medicated feed under EU legislation?
An oral CBD product for animals can cross into “medicated feed” territory if it contains, or even just claims to contain, substances with medicinal properties. If you see therapeutic claims or promises of disease prevention, that’s usually the tipping point. The authorities don’t mess around with this stuff—EU law is pretty clear.
Once a product falls under medicated feed, it needs official authorisation under veterinary medicines legislation. Mixing feed with anything considered medicinal brings a whole extra layer of rules, way beyond the usual feed regulations.
It’s not just about what’s inside, either. How you present or market the product matters a lot. Even if two products have the same formula, the wording and claims can change how regulators see them. That’s why we’re careful with our product info—to keep it within the feed category and steer clear of anything that sounds medicinal.
Disclaimer
Candrofera is intended for external animal care use only. It is not a veterinary medicinal product, animal feed, or biocidal product, and it is not intended to diagnose, treat, cure, or prevent any disease.
